Renowned Psychiatrists on Drug Company Payrolls
Belief:
Hot, Steamy Mormons: Are the Latter Day Saints Getting Sexy?
Liz Langley
Corporate Accountability and WorkPlace:
Transforming the Rust-Belt into a Green Belt
DrugReporter:
L.A. City Council Votes to Reduce Pot Dispensaries by 90%
Phillip S. Smith
Environment:
11 Ways to Make Your Holiday Economically and Environmentally Friendly
Sarah Sloane
Food:
The 6 Weirdest, Scariest Processed Foods
Brad Reed
Health and Wellness:
Are Americans a Broken People? Why We've Stopped Fighting Back Against the Forces of Oppression
Bruce E. Levine
Immigration:
High Unemployment Rates Frame the Immigration Debate
Marcelo Balive
Media and Technology:
10 Biggest Sports Sex Scandals of All Time: How Does Tiger Woods Rate?
David Rosen
Movie Mix:
Disney Apocalypse: Why 2012 Sucks
Alexander Zaitchik
Politics:
Afghanistan: How the War Hawks Caged Obama
Robert Parry
Reproductive Justice and Gender:
Is Taxing Plastic Surgery Really an Infringement on Women's Rights?
Alexandra Suich
Rights and Liberties:
Meet Joe Bageant: One of America's Best Redneck Populist Writers
Sex and Relationships:
Why Fake Optimism Is the Worst Way to Deal with Life's Problems
Liz Langley
Take Action:
G-20 Meetings: Nothing Much Happened in the Suites, and There Was Too Much Punch in the Streets
Laura Flanders
Water:
Damning New Evidence Raises Concerns About Threats to New York's Water from Gas Drilling
Byard Duncan
World:
Explosions and Fraught Negotiations Show Iraq Struggling to Emerge From U.S. Shadow
Abeer Mohammed, Neil Arun
Earlier in 2008, Senator Charles Grassley, R-Iowa, was particular troubled by what investigators told him about psychiatry’s premier professional organization, the American Psychiatric Association (APA), described by the New York Times as "the voice of establishment psychiatry." After he learned that the president-elect of the APA, Alan Schatzberg of Stanford University, had $4.8 million stock holdings in a drug development company and that the APA itself was heavily dependent on drug-company financing, Grassley wrote a letter to the APA stating, "I have come to understand that money from the pharmaceutical industry can shape the practices of nonprofit organizations that purport to be independent in their viewpoints and actions."
Recent studies reveal some of how drug company money has compromised the objectivity of drug research. Psychological Medicine in November 2006 reported that drug studies funded by pharmaceutical companies show positive results for psychiatric drugs 78 percent of the time, while drug studies without pharmaceutical company funding show favorable results only 48 percent of the time. This was discovered after examining 301 articles that were published between 1992 and 2002 in the American Journal of Psychiatry, Archives of General Psychiatry, Journal of Clinical Psychiatry, and Journal of Clinical Psychopharmacology.
Also reported by Psychological Medicine was that the percentage of studies sponsored by drug companies increased from 25% in 1992 to 57% in 2002. Currently, it is increasingly rare for a drug study not to be funded by the drug’s manufacturer.
Why are so many doctors unaware of just how poorly antidepressants have actually fared in studies? The New England Journal of Medicine (January 17, 2008) reviewed both published and unpublished antidepressant studies registered with the FDA between 1987 and 2004 on twelve antidepressants, and it reported that most studies with negative results were never published in journals. While 94 percent of antidepressant studies published in journals show antidepressants to be more effective than placebos, only 51 percent of all registered studies were determined by the FDA to show antidepressants superior to placebos.
The damage to the general public caused by drug company corruption of psychiatry goes beyond the cover up of the ineffectiveness and dangers of drugs. Drug company corruption of psychiatry has also resulted in a disregard of non-drug solutions for emotional and behavioral difficulties. In response to his corruption charges, former NPR host Frederick Goodwin told the New York Times that because he consults for so many drug makers at once that he has no particular bias, "These companies compete with each other and cancel each other out." Using Goodwin’s logic, if a politician is on the take from every oil corporation, then that politician has no conflict of interest with regard to energy policy.
Even before the extensive media coverage of the 2008 Congressional investigations of psychiatry, a 2006 Gallup poll revealed that the American public had relatively low confidence in psychiatrists’ honesty and ethics. When Americans were asked about the "honesty and ethical standards" of several professions, only 38 percent of respondents had a positive opinion of psychiatrists, much lower than the 69 percent positive rating for other medical doctors (nurses topped the list of professionals with an 84 percent positive rating).
When Gallup published the results of it its honesty and ethical standards poll, the American Psychiatric Association concluded that the problem of Americans’ lack of confidence in the honesty and ethics of psychiatrists is not with psychiatrists but with an ignorant American public. Commenting on the Gallup poll, a spokesperson for the APA in the Psychiatric News (an APA publication) concluded that psychiatrists need "to educate the public about who we are and what it is that we do."
How arrogant does an authority need to become before it loses its authority? How corrupt does an authority need to become before it loses its authority? How many times does an authority get to be wrong before it loses its authority? And how many bad apples does it take for Americans to suspect the entire barrel?
The good news is that while Americans often have no choice but to deal with many arrogant, corrupt, ignorant institutions, most adults are not actually forced to hand over their emotional and behavioral problems to establishment psychiatry.
See more stories tagged with: drug companies, apa, psychiatry
Bruce E. Levine, Ph.D., is a clinical psychologist and author of Surviving America's Depression Epidemic: How to Find Morale, Energy, and Community in a World Gone Crazy (Chelsea Green, 2007).
Liked this story? Get top stories in your inbox each week from AlterNet! Sign up now »
You've chosen to turn comments off for the entire site. Would you like to turn them back on?
Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.